- Home
- NTWK vs DXR Comparison
NTWK vs DXR Comparison
Compare NTWK & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTWK | DXR |
|---|---|---|
| Founded | 1997 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.6M | 59.0M |
| IPO Year | 1997 | 1995 |
Fundamental Metrics
Financial Performance| Metric | NTWK | DXR |
|---|---|---|
| Price | $4.51 | $11.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.5K | ★ 40.0K |
| Earning Date | 05-15-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 316.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $73,088,687.00 | $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ 13.40 | N/A |
| 52 Week Low | $2.73 | $8.56 |
| 52 Week High | $5.75 | $14.76 |
Technical Indicators
Market Signals| Indicator | NTWK | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 70.63 | 59.61 |
| Support Level | $4.20 | $9.43 |
| Resistance Level | $4.57 | $12.08 |
| Average True Range (ATR) | 0.16 | 0.76 |
| MACD | 0.06 | 0.12 |
| Stochastic Oscillator | 73.54 | 65.96 |
Price Performance
Historical ComparisonAbout NTWK NetSol Technologies Inc.
NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.